🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will examine the safety and effectiveness of a bone marrow trans...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Start Date
2023-10-01
Trial ID
NCT05900401
The purpose of this study is to examine how effective rituximab or tocilizu...
Status
Active Not Recruiting
Location
Johns Hopkins
Start Date
2020-09-25
Trial ID
NCT04375228
Treatments Being Tested
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
The purpose of this study is to determine whether the rituximab administrat...
Status
Completed
Location
Hospital Infanta Cristina
Start Date
2004-09
Trial ID
NCT01124526
Treatments Being Tested
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Status
Completed
Location
University of Arizona Cancer Center - North Campus /ID# 16721
Start Date
2009-07-21
Trial ID
NCT00788684
Rituximab is the first drug approved by the United States Food and Drug Adm...
Status
Terminated
Location
University of Alabama
Start Date
2012-05
Trial ID
NCT01586858
Treatments Being Tested
To determine what side effects and what clinical effect, if any, the admini...
Status
Completed
Location
Research site
Start Date
2002-11
Trial ID
NCT00048555
Treatments Being Tested
The primary purpose of the study will be testing the dosing of temozolomide...
Status
Terminated
Location
Cedars Sinai Medical Center
Start Date
2010-10-14
Trial ID
NCT01235793
Treatments Being Tested
The purpose of this study is to determine how children with a history of se...
Status
Completed
Location
University of California, Los Angeles
Start Date
2004-10
Trial ID
NCT01713855
Treatments Being Tested
This study will assess the efficacy and safety of mosunetuzumab in combinat...
Status
Active Not Recruiting
Location
City of Hope Cancer Center
Start Date
2022-04-25
Trial ID
NCT05171647
Treatments Being Tested